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Xeroderma pigmentosum (XP) occurs with high fre-
quency in Egypt and a continuation of our field studies 
has identified representatives of the 3 major complemen-
tation groups A, C, and variant. Group A patients, with 
one exception, showed very early onset of sun sensitivity 
and development of skin cancers, and microcephaly and 
mental retardation. The exceptional group A patient was 
35 yr old, with normal stature and intelligence who had 
2 normal children. DNA repair was as low in his cells as 
in other group A cases. Group C patients showed a 
slightly slower onset of sun sensitivity and had no cen-
tral nervous system disorders. The variants showed later 
onset of sun sensitivity and no skin cancers evident at 
the time of observation (about 20 yr of age). No sun 
sensitivity was present in the 25 heterozygotes we ob-
served, nor reportedly in the additional 60 not yet ob-
served. This ' indicates that only homozygosity for XP 
genes increases risks of skin cancer. 
Cell cultures from both normal persons and these XP 
patients reached in vitro "senescence" at similar passage 
levels. Groups A and C appear to have lost different 
major gene products that are involved in the excision of 
UV damage from DNA, but the residual repair in XP-C 
cells facilitates more recovery of DNA synthesis than in 
other groups. This may contribute 'to the higher in vitro 
survival in culture and milder clinical symptoms in 
group C as compared to group A. XP variants appear to 
have lost a gene product that permits normal cells to 
replicate, uninterrupted by DNA damage, and conse-
quently synthesize DNA in smaller pieces than normal. 
Xeroderma pigmentosum (XP) is a rare skin disorder that is 
unusually frequ ent in certain parts of the world, most notably 
Egypt and other parts of North Africa [1]. The reason for the 
high frequency in these areas is unknown, although possible 
heterozygote advantages associated with other endemic dis-
eases such as schistosomiasis have been suggested [2]. We 
previously reported a study of the clinical features and DNA 
repair defects in 7 Egyptian patients [1] who were classified 
into the 2 most common complementation groups, A and C. 
Egypt presents an invaluable resource in which we can observe 
a large number of patients usually from large kindreds who 
experience a year round exposure to intense sunlight. Differ-
ence", in the relative contributions to the clinical phenotype of 
the genetic component and the environment should therefore 
be easier to ascertain in this part of the world than elsewhere 
where comparisons between persons in different complemen-
tation groups are complicated because of wide variations that 
occur in the amount of sunlight exposure. As our investigations 
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of Egyptian patients were continued a number of new obser-
vations pertinent to this disease have been made and a prelim-
inary report is presented here. 
CLINICAL OBSERVATIONS 
We investigated the clinical characteristics, and took blood 
samples, skin biopsies or both from among a total of 19 cases, 
8 reported previously in 1978 [1] and 11 here, while we assessed 
the health status and took blood samples of as many sibs and 
parents as possible (Table 1). In the EgyPtian climate XP 
showed onset early in life with the disease becoming clinically 
recognizable within their first decade (Fig 1). Group A patients, 
with one exception, had microcephaly and mental deficiency 
that is characteristic of the majority of patients in this group, 
and showed very early onset of skin symptoms. The exceptional 
group A patient, XP13CA (Table I), showed neither microceph-
aly or marked mental deficiency, and had 2 normal children at 
the time of observation (age 35). He had had invasive carcinoma 
of the nose. The DNA repair level of his fibroblasts (XP13CA) 
was as low as other group A cells in this study and less than the 
group C. Group C patients showed a slightly later onset of 
symptoms, but most had come under clinical observation before 
age 10. One of the XP variants in our sample (XPI0CA) showed 
mild symptoms with normal intelligence and increased pigmen-
tation over the upper cheeks (Fig 1); she had a sister said to be 
similarly affected. The condition of XPlOCA had been diag-
nosed at the age of 10, and although there had been no skin 
tumors at the time of observation (age 19), her condition 
worsened strikingly soon after. 
Outstanding among the clinical features of actinic skin dam-
age in many of these patients were: invasive carcinomata of the 
face that had in some cases destroyed portions of the nose, 
leukoplakia, or tumors of the tip of the tongue in 6 patients 
(Fig 1), and photophobia in almost all cases. The lingual neo-
plasia presumably arose through occasional sun exposure to the 
tip of the tongue, and has been observed in other XP patients 
but rarely emphasized as a common feature of XP (Table I) 
[3]. 
Most of the affected families in Egypt are large which affords 
the opportunity to assess the phenotype of many heterozygotes. 
Neither the 15 parents nor the 14 sibs without XP that we 
examined showed signs or symptoms of sun hypersensitivity. 
From interviews, we ascertained that none other than definite 
homozygotes among relatives showed sun hypersensitivity. If 
we assume that all parents are heterozygotes and assume that 
67% of the sibs will be heterozygotes, then we have information 
that approximately 93 heterozygotes are said to be asympto-
matic. This contrasts with recent studies [4] which reported 
sun sensitivity in a small number of heterozygotes. However 
because that sun sensitivity was concentrated in just a few 
families [4] it may not be representative of XP heterozygotes in 
general. Our observations of families in which all heterozygotes 
had experienced intense sun exposure without exhibiting symp-
toms suggests that the XP gene significantly increases the skin 
cancer risk only in homozygotes. 
96 
Blood groups in XP families that we have so far analyzed, 
and will report in detail later, do not appear to support the 
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TABLE 1. Clinical characteristics of Egyptian xeroderma pigmentosllm cases 
Catalog number Age at onset of Photopho. Neoplasia Sibs' Parental symp· Case Group CNS· of cell linea skin symptoms bia Tongue Skin XP Normal toms 
XPICAd GM2990 A lyr + + + 1 5 None (2) 
XP2CA" GM2991 A 1 + + + 2 5 None (2) 
XP3CA GM2992 C 3 + + 1 4 None (2) 
XP4CA GM2993 C 3--4 + + + 0 6 None (2) 
XP5CA GM2994 A 1 + + 0 5 None (2) 
XP6CN GM2995 C 11 mo + +~ XP8CA 3 None (2) 
XP7CA GM2997 C 9 mo + 0 2 None (2) 
XP8CN GM2996 C 4 mo XP6CA None (2) 
XP9CA( AG3960 NDh + 3 6 None (2) 
XPIOCA AG3961 Variant 10 + 4 5 None (2) 
XPllCA AG3962 C 3 + + + 1 6 None (2) 
XP12CA AG3963 C ND ND 0 7 None (2) 
XP13CA AG3964 A ND ND + 0 3 Unknown 
XP14CA AG3965 C 3 + + + 0 5 None (2) 
XP15CA AG4317 ND 5 + 0 5 None (2) 
XP16CA( AG4318 ND ND + +~ 3 6 None (2) 
XP17CA AG4316 ND 3 + +~ + 1 4 None (2) 
XP18CA None ND 4 ND + 0 3 None (2) 
XP19CA None ND 1.5 1 7 None (2) 
XP20CA None ND ND + + + ND ND ND 
"Numbers prefixed with GM or AG identify cell lines in the cell bank of the Institute for Medical Research, Camden, N.J. 
• Microcephaly and mental deficiency probably from birth. 
C Sibs that died in infancy without evaluation are not recorded in this list. 
d Cousins . 
• / Sibs. 
N Leukoplakia. 
h Not determined. 
linkage of XP to the ABO locus previously reported in Egyptian 
families [5]. No linkage has been found between XP and HLA 
antigens either in Middle Eastern families [6]. Mapping of the 
XP locus (or loci) and determination of its linkage to other loci 
is one of the objectives in our study in the Egyptian population. 
CYTOLOGICAL OBSERVATIONS 
Cell Culture Studies 
We have carried many of these as well as other XP cell lines 
in culture until "senescence" and found no significant difference 
between the number of passages obtained for XP and normal 
cell lines. One each of the normal and XP cell lines came from 
donors in their 80's (Table II) and these provided slightly fewer 
passages before senescence. The DNA repair defects character-
istic of XP therefore did not contribute to premature in vitro 
senescence. Similarly, patients themselves do not conspicuously 
appear to age prematurely. Theories of aging which depend on 
t he accumulation of unrepaired damage as a critical step [7,8] 
are therefore not supported by in vitro or clinical studies of XP. 
Complementation Studies 
Hybridization of cells from those of our recently developed 
Egyptian XP cell lines with those from previously classified XP 
lines of complementation groups A and C permitted classifica-
tion of our new lines [1 ,10,12,14-16]' Each of these falls into 
one of the common groups, A and C (Table I, III) . The fre-
quencies of affected Egyptian XP patients in the different 
groups (Table III) indicate similar numbers of groups A and C. 
It should be noted that this represents case frequencies, not 
gene frequencies. The case frequency does not necessarily re-
flect true gene frequency because of both variations in expres-
sion or penetrance of the gene as well as variations in the 
amount of sunlight required to induce clinically important 
symptoms. Fewer individuals might be observed in groups A 
and D because of the severe developmental and neurological 
disorders that might be associated with diminished parental 
fertility or fetal wastage. Alternatively these neurological symp-
toms could make such XP cases more noticeable in climates 
such as those of Northern Europe and the British Isles where 
symptoms in other groups, especially C, E, and variant, could 
be so mild as to be unnoticed. Such an effect could contribute 
to the apparently higher proportion of group D patients in such 
regions (Table III). Supportive of such reasoning are recent 
findings that the "pigmented xerodermoid," a form of XP with 
mild symptoms described in Germany, is identical to the XP 
variant in vitro [13]. The patients showed no clinical symptoms 
until after age 40, whereas the XP variants we detected in 
Egypt (XP10CA) and from elsewhere in the Middle East (13) 
showed much earlier onset, by 10 yr of age, with much more 
severe symptoms. 
DNA Repair Measurements Using Cytosine Arabinoside 
With the exception of XP variants, all of our XP cell lines 
have severe deficits in DNA repair. This was observed by low 
levels of unscheduled DNA synthesis [9] and low levels of 
endonucleolytic incision during repair of UV damage [1] (Fig 
2). This method for detecting incision uSeS cytosine arabinoside 
(ARA-C) to block the polymerization and completion of re-
paired regions [11]. Single-strand breaks therefore accumulate 
as repair starts but cannot be completed (Fig 2). XP cells in 
group A showed fewer breaks than in group C, consistent with 
the lower levels of repair seen in group A cells by other methods 
[12]. Group C appeared heterogeneous with different numbers 
of breaks seen in various cell lines [1] (Fig 2). This method gave 
a frequency of endonucleolytic incision of 0 to 5% of normal for 
group A cells, 13 to 20% of normal for group C, and 100 to 150% 
for XP variants [1,13]. 
DNA Replication in XP Variants 
The XP variant cell line (XPlOCA) was defined in terms of 
its normal unscheduled DNA syn thesis and the characteristic 
abnormal response dw-ing semiconservative DNA synthesis 
after UV irradiation [13]. Variant cell types respond to UV 
damage as if they have lost a gene product that permits normal 
cells to replicate without inten-uption at damaged sites (UV-
induced pyrimidine dimers). The consequence of this loss is 
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FIG l. A, Xeroderma pigmentosum (XP) patient of complementation group C (XP4CA). B, XP patient of variant group (XPIOCA). C, XP 
patient of complementation group A. D, Pendimculated lingual neoplasm in patient of complementation group C (XP14CA). 
that replication forks are blocked more frequent ly and at lower 
doses in XP variant cells than in normal cells [13,17,18]. This 
is illustrated by t he size distribution of 3H pulse labeled DNA 
analyzed in alkaline sucrose gradients [Fig 3]. After a low UV 
dose (1.3 J /m2 254 nm) that only produces about one damaged 
site per replicating unit (replicon), normal cells show little 
evidence for production of low molecular weight DNA strands. 
The variant (XPlOCA) exhibits a peak of low molecular weight 
strands close to the size expected if each replicating fork is 
stopped by a pyrimidine dimer [19]. If irradiated cells are 
allowed to grow after labeling, we have previously shown that 
both normal and variant cells are able to link the labeled 
strands to high molecular weight DNA [27] which indicated 
that even XP variants do have the capacity to complete repli-
cation despite the frequent interruptions of chain growth. 
Some Characteristics of the DNA Repair System in Different 
Complementation Groups 
In our previous study, we suggested an interpretation for the 
mul t iple co.nplementation groups and their relative frequencies 
in XP [1]. Since most complementation groups contain one or 
more patients who are known to come from consanguineous 
malTiages, it can be assumed that cells within one complemen-
tation group are homozygous at a particular locus. Complemen-
tation groups A through G all appear to involve an early step 
in excision repair associated with recognition of damaged sites 
and incision of DNA. The variant [20] may involve both a 
defect in later stages in excision repair associated with poly-
merization and/ or ligation [21 ,22J that may produce secondary 
alterations in DNA replication [23] and a primary defect af-
fecting replication of damaged DNA [13,17]. The high fre-
quency of groups A and C suggests that these groups may 
represent major, large proteins involved in an early step of 
incision for which t here are many potentially mutable sites 
resulting in loss of function. The infrequent occurrence of other 
groups suggests that these may represent small proteins or 
polypeptides with few potential mutational sites at risk, or 
proteins whose function comes under stringent selection crite-
ria . This hypothesis can be tested for cells in group C by using 
a method recently developed in which excision repair of UV 
damage is inhibited by exposure to methyl methane sulfonate 
JUly 1981 
TABLE II. Passage levels at which senescence occurred in various 
normal and xeroderma pigmentosum fibroblast cell lines tram 
Egyptian and other donors 
Ce ll type 
Normal newborn (foreskin), HFl 
Normal adult, GM2881 
Normal adult (84 yr), PL 
Cockayne's syndrome 
XPA 
GM2090 
GM544 
XPC 
XP7CA 
XPIMI 
XPD 
. XPlBR 
XP7BE 
XP3NE 
xp-v 
XP1l5LO 
XP5MA (85 yr) 
Passage leve l at senescence" 
26 
24 
18 
Beyond 22 
Beyond 24b 
Beyond 20" 
22 
24 
27 
26 
Beyond 30" 
27 
19 
" Cells were transferred once per week and diluted 1 to 4. Senescence 
was defined as the failure of cell division to result in a confluent flask 
in 1-2 weeks. Senescence occurred suddenly within 1 or 2 passages and 
was associated with the appearance of necrotic and abnormal cells. 
b At these passage numbers cells were still actively growing. 
TABLE III. Relative frequencies of various xeroderma pigmentosum 
complementation groups from different populations" 
Complementation group 
Population (No. of patients) 
A B C 0 E F G Variant 
North America 3 1 5 5 0 0 0 2 
Europe and Britain 10 0 14 8 2 0 2 5 
Japan 21 0 I I 0 2 0 9 
Egypt" 7 0 12 0 0 0 0 5 
" See reference 1 and Table I. 
b This study assumes that affected relatives of the patients we 
investigated have the same complementation group as do the pro bands. 
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FIG 2. Alkaline sucrose gradient profiles of "'CdThd uniformly la-
beled single stranded DNA from normal and xeroderma pigmentosum 
(XP) groups A and C fibroblasts irradiated with UV light (13 J / m2) 
and grown for 5 hr in ara-C (10- 5 or 10- (; M) plus hydroxyurea (2 mM). 
Normal, 0 unirradiated control, 0 , • UV irradiated and grown in 10- (; 
or 10- 5 M ara-C respectively. XP group A , 0 XPICA, • XP5CA, both 
. irradiated and grown in 10- 5 M CA. XP group C. 0 XP4CA, 0 XP7CA, 
• XP8CA, all irradiated and grown in 10- 5 Mara-C. The decrease in 
the molecular weights in normal cells corresponds to accumulation of 
5-6 single-strand breaks at excision repair sites per control molecules 
(1.6 X 108 daltons) . Sedimentation from right to left at 25,000 revs/min 
for 4 m·. 
(MMS), an agent that directly alkylates proteins (including 
repair enzymes) as well as DNA [24,25]. In this method we 
measure the amount of unscheduled DNA synthesis in normal 
and XP cell cultures exposed to UV and MMS and compare 
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FIG 3. Alkaline sucrose gradients of 3HdThd labeled single-stranded 
DNA from norm.al (HFl) and XP variant (XPlOCA) fibroblasts irra-
diated with various doses of UV light and grown for 60 min before 
labeling for 10-15 min with 10 f,lCi j ml 60 Ci/mmole 3HdThd and 
harvested immediately, 0 control, .5 J / m2 UV. Sedimentation from 
right-to-Ieft at 25,000 revs/min for 4 hr. 3H counts per min are normal-
ized to the same number of cells in each gradient. Arrows (14C) indicate 
position of pill'ental DNA of single-stranded molecular weight 2 x lOS 
daltons. 
this with that occurring after UV exposure alone. After correc-
tion for unscheduled synthesis occurring from MMS-induced 
damage itself, the relative amounts of UV -induced unscheduled 
DNA synthesis as a function of MMS concentration are repre-
sented by a straight line on a semilog plot (Fig 4). This method 
can only be applied to XP groups such as C, D , and variant 
which still perform measureable amounts of unscheduled DNA 
synthesis. The results indicate that unscheduled DNA synthesis 
in a group C (XP7CA) cell line is more resistant to inactivation 
by MMS than unscheduled DNA synthesis in group D and 
normal cell lines. Application of a simple target theory to such 
inactivation curves [24,25J suggests that the protein system still 
active in unscheduled synthesis in a group C cell line is much 
smaller than normal. Hence, the mutations represented by 
group C cell lines may cause the loss of function of a large 
major protein of the excision repair system as we predicted 
from the population studies [1]. 
DNA Replication in XP Groups 
Immediately after irradiation with moderate to high UV 
doses (above 2 J / m 2 254 nm) cells replicate DNA in shorter 
pieces than normal due to blocking or interruption of replication 
at damaged sites [13,26,27]. Later they begin synthesizing DNA 
in sizes close to that found in unirradiated cells f26l The latter 
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FIG 4. Relative amount of unscheduled synthesis (the ratios of that 
in MMS treated cultures divided by that in untreated cultures) induced 
by 13 to 26 J / m2 UV light during 60 min "HThd labeling of normal or 
XP cells when the UV is immediately followed by various doses of 
methylmethane sulfonate before labeling. Mean grain counts deter-
mined over 40 lightly labeled cells in autoradiographs and relative 
unscheduled synthesis corrected for that induced by methylmethane 
sulfonate alone .• normal cells (HFl), 0 XP7CA group C, 0 XPIBR 
group D. 
recovery process depends on the excision repair capacity of a 
cell, as one factor. Excision defective and variant cells recover 
more slowly than excision competent cells [18,26]. Cells in 
groups A and C both have low but different levels of excision 
repair and the small amount detectable in group C cells appears 
to facilitate greater recovery of DNA synthesis after UV irra-
diation than in group A (Fig 5). Therefore, the small amount of 
repair in XP group C cells has considerable functional value to 
the cells in facilitating recovery of DNA synthesis, and this may 
contribute in part to the higher survival in vitro [28] and the 
milder clinical symptoms without neurological complications 
[14]. 
CONCLUSION 
In the sizeable population of individuals with XP in Egypt, 
we are attempting to unravel the relative contributions of 
genetic and environmental factors to this disease. That high 
intensity of sunlight throughout the country results in maximal 
expression of the symptoms due specifically to sunlight damage. 
The environmental contribution 'to the phenotype should be 
more uniform than when cases are compared from diverse 
regions such as Japan, Britain, Morocco, and the U.S. Attempts 
to explain the genetic basis for heterogeneity in the disease 
should therefore be facilitated. The differences we observed 
between groups A, C, and variant should be attributable to the 
genetic differences in the DNA repair and replication defects. 
. Some striking clinical heterogeneity is already evident within 
group A and C where patients with and without neurological 
disorders are evident. The absence of clinical signs of sun 
hypersensitivity in the skin of heterozygotes suggests also that 
there is negligible risk of skin cancer associated with heterozy-
gosity for the XP gene. Continued investigation of this popu-
lation will further our undef3tanding of the relationships be-
tween clinical symptoms, genetic linkage, DNA d~mage, repair, 
and replication in XP as a model for carcinogen-induced cancer 
in man. 
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FIG 5. Alkaline sucrose gradients of no~mal .or . xeroderma pig~e~ 
tosum (XP) cells grown for 1 or 5 hr after LrradiatlOn WIth 5 J/M V 
light before labeling with :JHdThd (10 /-ICi/ml 60 Ci/mole, 10 min) Il ll~ 
then immediately analyzed in alkaline gradients. Top: normal (S~ 
cells, center XP2CA group A cells, bottom XP7CA group C cells. 
control, no irradiation. 0 1 hr after irradiation, 0 5 hr after irradiatlOll. 
Sedimentation from right-to-left at 25,000 revs/min for 4 hr. "H coullts 
per min are normalized to the same number of cells in each gradiellt. 
Arrow ('·C) denotes position of parental DNA of single-stranded rIl°li 
lecular weight 2 x 108 daltons. The percentage of repair for each ce 3 
type is the ratio of the amount of unscheduled synthesis induced by 1 
Jim' in comparison to normal cells . 
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